Danaher, headquartered in Washington, D.C., employs 61,000 people and operates in Biotechnology, Life Sciences, and Diagnostics, offering products and services for medical and industrial applications.
DHR has been in the news recently: In April, discussions around market volatility included predictions from Goldman Sachs regarding profitable call buying during the earnings season, with companies like Danaher expected to report soon. The S&P 500 has experienced a decline of over 1%, reflecting ongoing uncertainty in the market.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.